Edition:
India

Cadila Healthcare Ltd (CADI.NS)

CADI.NS on National Stock Exchange of India

437.85INR
11:47am IST
Change (% chg)

Rs-2.40 (-0.55%)
Prev Close
Rs440.25
Open
Rs441.95
Day's High
Rs446.00
Day's Low
Rs436.65
Volume
151,428
Avg. Vol
975,416
52-wk High
Rs560.00
52-wk Low
Rs329.40

Select another date:

Fri, Dec 29 2017

BRIEF-Cadila Healthcare's Zydus Gets Final Nod From U.S. FDA For Clomipramine Hydrochloride Capsules

* SAYS ZYDUS GETS FINAL APPROVAL FROM U.S. FDA FOR CLOMIPRAMINE HYDROCHLORIDE CAPSULES USP

BRIEF-Cadila Healthcare Says ‍Zydus Gets U.S.FDA Nod For Drug to Treat Hypertension, Chest Pain

* SAYS ‍ZYDUS RECEIVES FINAL APPROVAL FROM USFDA FOR NIFEDIPINE EXTENDED-RELEASE TABLETS USP​

BRIEF-Cadila Healthcare Says ‍Zydus Got USFDA Nod For Two Drugs

* ‍ZYDUS GETS FINAL APPROVAL FROM USFDA FOR PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE TABLETS & NITROFURANTOIN CAPSULES USP (MACROCRYSTALS)​

BRIEF-Cadila Healthcare's Zydus Gets Final Nod From U.S. FDA For Clozapine Tablets

* SAYS ZYDUS GET FINAL NOD FROM U.S. FDA FOR CLOZAPINE TABLETS USP

BRIEF-Cadila Healthcare Says Zydus Gets Tentative Approval From U.S. FDA For Pregabalin Capsules

* SAYS ZYDUS GETS TENTATIVE APPROVAL FROM U.S. FDA FOR PREGABALIN CAPSULES

BRIEF-Cadila Healthcare's Zydus, ICMR Launch Diagnostic Kits To Detect Rare Infectious Diseases

* INDIAN COUNCIL OF MEDICAL RESEARCH, ZYDUS LAUNCH DIAGNOSTIC KITS TO DETECT NEGLECTED INFECTIOUS DISEASES IN LIVESTOCK

BRIEF-Cadila Healthcare Says ‍Zydus Gets Final Nod From U.S. FDA For Candesartan Cilexetil And Hydrochlorothiazide Tablets​

* SAYS ‍ZYDUS GETS FINAL APPROVAL FROM U.S. FDA FOR CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS

BRIEF-Cadila Healthcare's ‍Zydus Gets Nod For Topiramate Extended-Release Capsules​

* ‍ZYDUS GETS FINAL APPROVAL FROM U.S. FDA FOR TOPIRAMATE EXTENDED-RELEASE CAPSULES

BRIEF-Zydus Cadila's anemia developmental candiate ZYAN1 named as Desidustat by WHO‍​

* WHO INN committee grants name Desidustat to Zydus Cadila's phase II anemia candidate, Zyan1‍​

BRIEF-India's Cadila Healthcare Sept-qtr consol profit up about 32 pct

* Sept quarter consol net profit 5.03 billion rupees versus profit of 3.80 billion rupees last year

Select another date: